menu Search

Empowering Healthcare Decisions.
Right at the point of Care.

Search
Powered by AI - Try searching for:
MORE
Dupilumab eases itch, disease activity in chronic spontaneous urticaria 21 May 2026
Patients with chronic spontaneous urticaria (CSA) who has uncontrolled disease despite treatment with H1-antihistamines may benefit from using dupilumab, which has been shown to reduce itch and urticaria activity in two phase III trials.
Treatment de-escalation safe in patients with ERBB2-positive early breast cancer and high TILs
13 May 2026
PD TEST Long Text Test Data - Webcast: Covid-19: What it means to your clinic. Practice pearls for the Asian primary care physician.
31 Mar 2026
Why are there fewer COVID-19 cases in children?
31 Mar 2026
StrongHER, TogetHER: A comprehensive review of obstetrical dilemma in endometriosis and infertility
16 Mar 2026
MPS, GSK issue joint commitment to patient safety focus
16 Mar 2026
‘Sandwich’ sequencing of adjuvant chemoradiation tied to less toxicity in advanced endometrial cancer
16 Mar 2026
Ministry of Health, state governments receive special allocation to help in battling COVID-19
24 Feb 2026
Low liver fat bad for the heart?
24 Feb 2026
Obesity isn't merely a weakness in one's character. Many other factors contribute to the difficulty in maintaining weight loss.
23 Feb 2026
Product Highlight-Arexvy
22 Feb 2026
MORE
PD TEST Long Text Test Data - Webcast: Covid-19: What it means to your clinic. Practice pearls for the Asian primary care physician. 31 Mar 2026;
Webcast: Covid-19: What it means to your clinic. Practice pearls for the Asian primary care physician.
StrongHER, TogetHER: A comprehensive review of obstetrical dilemma in endometriosis and infertility
16 Mar 2026
Product Highlight-Arexvy
22 Feb 2026
Pharma head: Technology will disrupt all aspects of healthcare
Pank Jit Sin, 22 Feb 2026
SHOW ALL

New Molecule

2 New

New Indication

2 New

New Brand

5 New

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
ADVANCED SEARCH
Markings
Shape
Form
Color 1
Color 2
Advertisement
MORE
[TEST DATA VA] 1320 - TUFF LIMITED
Doctors
[TEST DATA AS] MEDU 1848
Doctors
[test data ws] course convrted my do not touch
Doctors
Advertisement
Advertisement
#1 Medical Resource Since 1963

What Is MIMS?

MIMS is a trusted, accurate and user-friendly medication information platform. Designed to empower both healthcare professionals and general public to support informed healthcare decisions, our leading drug directory provides clear, reliable information on prescription drugs, over-the-counter medications and other medical resources.

  • Clinical Independence
  • Evidence-based Data
  • Regulatory Alignment
Learn More About Us
Trusted by 2.1 million HCPs
17 Countries & Regions
Australia Malaysia Philippines Singapore Vietnam Thailand

Frequently Asked Questions

Absolutely. Our database is continuously updated by medical editors and references authoritative sources, ensuring accuracy and credibility.

Yes. You can access MIMS.com on desktop or mobile, and we also offer an app for on-the-go use.

Use the search bar located at the top of the homepage and enter either the brand name or generic name of the drug.

Go to "Diseases" and use the search bar located at the top of the page and enter the name of the disease.

Go to "Medical News & Updates" to access latest news and medical updates in MIMS.com
Explore More FAQs